Troy A. Rafferty
Mr. Rafferty is a shareholder at Levin, Papantonio, Thomas, Mitchell, Rafferty & Proctor, P.A. He litigates mass tort, pharmaceutical and other personal injury cases throughout the country. Mr Rafferty has been recognized as one of the country's top lawyers through inclusion in the publication The Best Lawyers in America. He has also been recognized as one of Florida's top lawyers by Florida Super Lawyers. He has received numerous jury verdicts and settlements in excess of $1 million.
Mr. Rafferty has been appointed to handle some of the nation's largest pharmaceutical and mass tort cases. He currently serves as co-lead counsel in the In re: Gadolinium Based Contrast Agent litigation which is filed U.S. District Court for the Northern District of Ohio. He was appointed by the U.S. District Court of the Eastern District of Louisiana to serve on the Plaintiffs Steering Committee in the national Vioxx Litigation which resulted in a $4.7 billion national settlement. He was also appointed to the Plaintiffs Steering Committee in the national Zyprexa Litigation in the United States District Court for the Eastern District of New York. This litigation resulted in a $700 million settlement on behalf of clients throughout the country. Mr. Rafferty was also one of the leading attorneys in the national Rezulin litigation which was filed in the Southern District of New York. In 2001 he and his partner obtained a $40 million jury verdict in Corpus Christy, Texas for a woman who took the diabetes drug Rezulin. He has tried numerous complex pharmaceutical cases throughout the country.
Mr. Rafferty is also active in the Florida Justice Association where he currently serves on the Board of Directors and numerous committees.
Mr. Rafferty is a frequent lecturer throughout the country to trial lawyers on mass tort litigation and general trial practice including topics such as (1) Building the Trial Package for a Pharmaceutical Case; (2) A Trial Package Presentation - Rezulin Cases; (3) Legal Malpractice and Ethics; (4) Rezulin Cases - The Opening Statement; (5) The Use of Technology During Jury Selection; (5) A Trial Package Presentation - Vioxx cases; (6) Zyprexa Litigation Update; and many more topics involving mass tort litigation and the use of technology in the courtroom.
He is currently licensed to practice law before all Florida state courts, the United States District Courts for the Northern and Middle Districts of Florida and the United States Court of Appeals for the Eleventh Circuit.
Mass Torts / Product Liability
Areas of Practice:
Mass Tort/Pharmaceutical Litigation
U.S. District Court Northern District of Florida
U.S. District Court Middle District of Florida
U.S. Court of Appeals 11th Circuit
Valparaiso University School of Law, Valparaiso, Indiana
Honors: Magna Cum Laude
Law Review: Valparaiso University Law Review, Editor
Michigan State University, 1991
Major: International Relations
James Madison College, 1991
Major: International Relations
Pharmaceutical Litigation: Recent Trends and Developments, Florida Justice Association Journal, Issue 522, August, 2007
With Contrast or Without Contrast - What is the Gadolinium Based Contrast Agent Litigation?, Florida Justice Association Journal, Issue 530, June, 2008
Building the Trial Package for a Pharmaceutical Case
A Trial Package Presentation - Rezulin Cases
The Scary Stuff: Legal Malpractice and Ethics
Rezulin Cases - The Opening Statement
The Use of Technology in Jury Selection
Zyprexa Litigation Update
Vioxx Trial Package Presentation
Vioxx Litigation Update
Professional Associations and Memberships:
American Bar Association
American Association for Justice
Florida Justice Association, 2008 - 2010
Board of Directors